Stifel Downgrades Core Laboratories to Hold, Lowers Price Target to $40

Stifel analyst Stephen Gengaro downgrades Core Laboratories (NYSE:CLB) from Buy to Hold and lowers the price target from $50 to $40.

Benzinga · 01/02/2020 11:46

Stifel analyst Stephen Gengaro downgrades Core Laboratories (NYSE:CLB) from Buy to Hold and lowers the price target from $50 to $40.